CSBR logo

Champions Oncology (CSBR)

Profile

Full Name

Champions Oncology, Inc.

Ticker Symbol

CSBR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 2, 2007

Indexes

Not included

Website

http://www.championsoncology.com

Employees

210

Key Details

Price

$7.69(+4.77%)

Market cap

$106.33M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$50.16M(-6.90% YoY)

Annual EPS

-$0.54(-38.46% YoY)

PE ratio

17.48

Next earnings date

Jul 18, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$7.69
CSBR price is $7.69

30-Day Relative Volume

1.03
CSBR 30-day relative volume is 1.03

Price Performance

Price Today change

+4.77%
CSBR price is up +4.77% today

Price YTD change

-10.27%
CSBR price is down -10.27% since January 1st

Price 1-year change

+53.8%
CSBR price is up +53.8% year-on-year

Price 3-year change

-6.9%
CSBR price is down -6.9% over the past 3 years

Price Range

Price All-time high

$25.80
CSBR price is currently -70.19% below its historical high of $25.80

Price 3-year low

$3.60
CSBR price is currently +113.61% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$106.33M
CSBR market capitalization is $106.33 million

Market cap 3-year change

-4.8%
CSBR market capitalization is down -4.8% over the past 3 years

Market cap All-time high

$195.04M
CSBR market capitalization is currently -45.48% below its historical high of $195.04 million

Market cap sector rank

49.22%
CSBR market capitalization is higher than 49.22% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.71%
CSBR shares outstanding is up +1.71% year-on-year

Shares Outstanding 3-Year Change

+2.25%
CSBR shares outstanding is up +2.25% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.88
CSBR beta is 0.88

200-day SMA

$6.59
CSBR price is currently +16.78% above its 200-day simple moving average

50-day SMA

$9.75
CSBR price is currently -21.09% below its 50-day simple moving average

RSI

35.92
CSBR 14-day relative strength index is 35.92

Volume

1.03
CSBR 30-day relative volume is 1.03

ATR

$0.81
CSBR average true range is $0.81

10-day Historical Volatility

95.71%
CSBR 10-day historical volatility is 95.71%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$50.16M
CSBR annual revenue is $50.16 million

Revenue Analysts estimate

$56.60M
CSBR annual revenue is currently -11.39% lower than the consensus analysts' forecast

Revenue 1-year change

-6.9%
CSBR annual revenue is down -6.9% year-on-year

Revenue Sector rank

46.14%
CSBR annual revenue is higher than 46.14% of companies in Healthcare sector

EPS

EPS

-$0.54
CSBR annual earnings per share is -$0.54

EPS Analysts estimate

$0.30
CSBR annual earnings per share is currently -280.00% lower than the consensus analysts' forecast

EPS 1-year change

-38.46%
CSBR annual earnings per share is down -38.46% year-on-year

EPS Sector rank

67.55%
CSBR annual earnings per share is higher than 67.55% of companies in Healthcare sector

Profit

Gross profit

$20.75M
CSBR annual gross profit is $20.75 million

Gross margin

41.38%
CSBR annual gross profit margin is 41.38%

Operating profit

-$6.92M
CSBR annual operating income is -$6.92 million

Operating margin

-13.80%
CSBR annual operating profit margin is -13.80%

Net income

-$7.28M
CSBR annual net profit is -$7.28 million

Net margin

-14.51%
CSBR annual net profit margin is -14.51%

Expenses

Total expenses

$57.08M
CSBR annual total expenses is $57.08 million

Operating expenses

$27.68M
CSBR annual total operating expenses is $27.68 million

Cost of goods sold

$29.40M
CSBR annual cost of goods sold is $29.40 million

Selling, general & administrative expenses

$18.13M
CSBR annual SGA is $18.13 million

Depreciation and amortization

$1.87M
CSBR annual depreciation & amortization is $1.87 million

Interest expense

-
CSBR annual interest expense value is unknown

Income tax

-$32.00K
CSBR annual income tax is -$32.00 thousand

EBIT & EBITDA

EBIT

-$6.92M
CSBR annual earnings before interest & taxes is -$6.92 million

EBITDA

-$5.05M
CSBR annual EBITDA is -$5.05 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$26.13M
CSBR annual total assets is $26.13 million

Non current assets

$12.49M
CSBR annual long term assets is $12.49 million

Current assets

$13.64M
CSBR annual total current assets is $13.64 million

Cash and cash equivalents

$2.62M
CSBR annual cash & cash equivalents is $2.62 million

Accounts receivable

$4.89M
CSBR annual accounts receivable is $4.89 million

Inventory

-
CSBR annual inventory value is unknown

Liabilities

Total liabilities

$28.04M
CSBR annual total liabilities is $28.04 million

Long term liabilities

$6.49M
CSBR annual total long term liabilities is $6.49 million

Current liabilities

$21.54M
CSBR annual total current liabilities is $21.54 million

Accounts payable

$5.80M
CSBR annual accounts payable is $5.80 million

Debt

Total debt

$7.43M
CSBR annual total debt is $7.43 million

Total debt 1-year change

-13.59%
CSBR annual total debt is down -13.59% year-on-year

Long term debt

$6.09M
CSBR annual long term debt is $6.09 million

Short term debt

$1.34M
CSBR annual short term debt is $1.34 million

Equity & Capital

Shareholders equity

-$1.90M
CSBR annual stockholders equity is -$1.90 million

Book value

-$1.90M
CSBR annual book value is -$1.90 million

Retained earnings

-$84.59M
CSBR annual retained earnings is -$84.59 million

Working capital

-$7.90M
CSBR annual working capital is -$7.90 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$6.14M
CSBR annual cash flow from operations is -$6.14 million

Cash from operations 1-year change

-254.51%
CSBR annual cash flow from operations is down -254.51% year-on-year

Cash from investing

-$836.00K
CSBR annual cash flow from investing activities is -$836.00 thousand

Cash from investing 1-year change

+70.89%
CSBR annual cash flow from investing activities is up +70.89% year-on-year

Cash from financing

-$527.00K
CSBR annual cash flow from financing activities is -$527.00 thousand

Cash from financing 1-year change

-4890.91%
CSBR annual cash flow from financing activities is down -4890.91% year-on-year

CAPEX

CAPEX

$836.00K
CSBR annual capital expenditures is $836.00 thousand

CAPEX 1-year change

-70.89%
CSBR annual capital expenditures is down -70.89% year-on-year

Free Cash Flow

Free cash flow

-$6.97M
CSBR annual free cash flow is -$6.97 million

Free cash flow 1-year change

-733.91%
CSBR annual free cash flow is down -733.91% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

41.38%
CSBR annual gross profit margin is 41.38%

Operating margin

-13.80%
CSBR annual operating profit margin is -13.80%

Net margin

-14.51%
CSBR annual net profit margin is -14.51%

ROA & ROE

ROA

-24.08%
CSBR annual return on assets is -24.08%

ROE

-532.46%
CSBR annual return on equity is -532.46%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

17.48
CSBR price to earnings ratio is 17.48

PE ratio Sector rank

31.86%
CSBR price to earnings ratio is higher than 31.86% of companies in Healthcare sector

PB Ratio

PB ratio

19.44
CSBR price to book ratio is 19.44

PB ratio Sector rank

96.63%
CSBR price to book ratio is higher than 96.63% of companies in Healthcare sector

PS Ratio

PS ratio

1.81
CSBR price to sales ratio is 1.81

PS ratio Sector rank

41.15%
CSBR price to sales ratio is higher than 41.15% of companies in Healthcare sector

Enterprise value

Enterprise value

$109.57M
CSBR enterprise value is $109.57 million

Enterprise value Sector rank

51.69%
CSBR enterprise value is higher than 51.69% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

13.00
CSBR EV/EBITDA is 13.00

EV/EBITDA Sector rank

85.84%
CSBR EV/EBITDA is higher than 85.84% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.63
CSBR annual current ratio is 0.63

Quick ratio

-
CSBR annual quick ratio value is unknown

Leverage

Debt to equity

0.00
CSBR annual debt to equity ratio is 0.00

Interest coverage ratio

-
CSBR annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

6
CSBR piotroski f-score is 6

Altman Z-Score

-1.57
CSBR altman z-score is -1.57

Analyst ratings

Recent major analysts updates

Mar 12, 25 Craig-Hallum
Buy
Dec 12, 24 Craig-Hallum
Buy
Sep 12, 24 Craig-Hallum
Buy
Mar 13, 24 Craig-Hallum
Hold
Sep 22, 23 Roth MKM
Buy
Mar 15, 21 Roth Capital
Buy
Nov 18, 19 Benchmark
Speculative Buy
Sep 20, 19 Roth Capital
Buy
Jul 24, 19 Janney Montgomery Scott
Neutral
Jul 24, 19 Janney Capital
Neutral

Institutional Ownership

Similar stocks

SLS logo
SELLAS Life Sciences (SLS)
ENTA logo
Enanta Pharmaceuticals (ENTA)
XBIT logo
XBiotech (XBIT)
MCRB logo
Seres Therapeutics (MCRB)
NAUT logo
Nautilus Biotechnology (NAUT)
ZTEK logo
Zentek (ZTEK)
Contineum Therapeutics Class A (CTNM)
INFU logo
InfuSystem Holdings (INFU)
TIL logo
Instil Bio (TIL)
  • What is the ticker symbol for Champions Oncology?
  • Does Champions Oncology pay dividends?
  • What sector is Champions Oncology in?
  • What industry is Champions Oncology in?
  • What country is Champions Oncology based in?
  • When did Champions Oncology go public?
  • Is Champions Oncology in the S&P 500?
  • Is Champions Oncology in the NASDAQ 100?
  • Is Champions Oncology in the Dow Jones?
  • When was Champions Oncology's last earnings report?
  • When does Champions Oncology report earnings?
  • Should I buy Champions Oncology stock now?

What is the ticker symbol for Champions Oncology?

The ticker symbol for Champions Oncology is NASDAQ:CSBR

Does Champions Oncology pay dividends?

No, Champions Oncology does not pay dividends

What sector is Champions Oncology in?

Champions Oncology is in the Healthcare sector

What industry is Champions Oncology in?

Champions Oncology is in the Biotechnology industry

What country is Champions Oncology based in?

Champions Oncology is headquartered in United States

When did Champions Oncology go public?

Champions Oncology's initial public offering (IPO) was on February 2, 2007

Is Champions Oncology in the S&P 500?

No, Champions Oncology is not included in the S&P 500 index

Is Champions Oncology in the NASDAQ 100?

No, Champions Oncology is not included in the NASDAQ 100 index

Is Champions Oncology in the Dow Jones?

No, Champions Oncology is not included in the Dow Jones index

When was Champions Oncology's last earnings report?

Champions Oncology's most recent earnings report was on Mar 11, 2025

When does Champions Oncology report earnings?

The next expected earnings date for Champions Oncology is Jul 18, 2025

Should I buy Champions Oncology stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page